
Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing... Avalo Therapeutics Inc is a clinical-stage precision medicine company that discovers, develops, and commercializes targeted therapeutics for patients with significant unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases. Its pipeline consists of product candidates advancing in development with ongoing clinical programs: AVTX-002, AVTX-007, and AVTX-006. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.91 | -17.1052631579 | 5.32 | 5.85 | 4.15 | 112047 | 4.70792635 | CS |
4 | -4.06 | -47.9338842975 | 8.47 | 9.6999 | 4.15 | 74889 | 6.33560854 | CS |
12 | -2.78 | -38.6648122392 | 7.19 | 11.23 | 4.15 | 70342 | 7.30658601 | CS |
26 | -6.84 | -60.8 | 11.25 | 16 | 4.15 | 84179 | 8.80040932 | CS |
52 | -7.05 | -61.5183246073 | 11.46 | 17.49 | 4.15 | 54091 | 9.4572279 | CS |
156 | -128.55 | -96.6832129964 | 132.96 | 1711.2 | 3.9501 | 7910197 | 34.61085673 | CS |
260 | -684.39 | -99.3597560976 | 688.8 | 1711.2 | 3.9501 | 6573859 | 39.26979506 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales